Pharmafile Logo
Pharmafocus logo
Advanced Search
cost_coins

Prescription costs vary wildly between high-income countries

June 13, 2017
Manufacturing and Production, Sales and Marketing medicine, prescription, prescription cost

A study originating out of Canada has laid bare the difference in cost of primary care prescription drugs between different …

News
sun_pharma

Sun Pharma rises again with FDA cholesterol drug approval

June 13, 2017
Manufacturing and Production Sun Pharma

Sun Pharma has had a rough time of late, the FDA has become more aggressive in its overseeing of manufacturing …

News
location-shanbally

FDA approves BioMarin’s Irish facility

June 13, 2017
Manufacturing and Production BioMarin, Ireland, cork, vimizin

The FDA has approved BioMarin’s bulk biologic manufacturing plant, based in Cork, Ireland. The facility will manufacture an ingredient of …

News
scotland_flag

SMC reverses decision on Opdivo for kidney cancer

June 12, 2017
Manufacturing and Production, Sales and Marketing BMS, Bristol-Myers Squibb, SMC, opdivo

The Scottish Medicines Consortium (SMC) has performed a U-turn on its decision regarding Opdivo (nivolumab), and will now allow patients …

News
untitled

European Medicines Agency: Staying consistent in a turbulent time

June 12, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, European Medicines Agency, brexit

With Brexit looming, the future of the EMA headquarters in London has been cast in doubt. Pharmafocus spoke to Marie-Agnes …

Feature
front_image

FlyPharma Conference 2017 – “Collaboration is the key”

June 12, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FlyPharma conference, PHARMA SUPPLY CHAIN, flypharma, supply chain

As the conference came to a conclusion, audience members were invited to offer their thoughts on what the overall message …

News
diabetes_injection

Type 2 diabetes directly linked to BMI

June 12, 2017
Research and Development, Sales and Marketing diabetes, type 2 diabetes

Research emerging from the American Diabetes Association’s meeting in San Diego has revealed that the likelihood of developing type 2 …

News
teva_copy

Teva conducts boardroom shuffle with four new faces

June 12, 2017
Medical Communications, Sales and Marketing

It is well-known that Teva Pharmaceutical has had a rough time of late, particularly in terms of employees. It has …

News

Sanofi and Regeneron posts positive Praluent cholesterol data

June 12, 2017
Research and Development, Sales and Marketing Regeneron, Sanofi, praluent

Sanofi and Regeneron were able to update its PCSK9 therapy Praluent with the positive data showing it could reduce levels …

News
abbvieuse_036_low

AbbVie loses $15 million Depakote birth-defect case

June 12, 2017
Sales and Marketing AbbVie, Abbott, Depakote

Court cases for the anti-seizure medicine Depakote continue to rumble on for AbbVie, with the latest case finding AbbVie liable …

News

High potency drugs – from molecule to market

June 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI

To print or download a PDF version of this article, click here.

Feature
White paper
top_ten_1

Top Ten most read pages on Pharmafile.com this week

June 9, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biggest news, biggest stories, top 10, top 10 stories, top stories, top ten

It’s been a week for successful trial news and for drugs being sped through the approval process. Particularly noteworthy is …

News

Continuous Manufacturing: Novartis’ experiment in the future of drug production

June 9, 2017
Manufacturing and Production, Medical Communications Novartis, continuous manufacturing

Continuous manufacturing has long been touted as the future of drug production. Pharmafile approached Novartis for more details about its successes in …

News

Lilly bolsters diabetes assets with $55m KeyBioscience deal

June 9, 2017
Medical Communications, Sales and Marketing Eli Lilly, KeyBiosciences

Eli Lilly has announced a strategic collaboration with KeyBioscience that sees the former company gain access to develop and commercialise …

News
actelion

Actelion spin-off hit by blow shortly before buyout

June 9, 2017
Medical Communications, Research and Development Actelion, Idorsia, J&J, JJ

Idorsia, the spin-off R&D company of Actelion, has been hit a blow even before it has left the ground. The …

News
fda_building

FDA calls for withdrawal of opioid product for first time in history

June 9, 2017
Medical Communications Endo pharmaceuticals, FDA, Scott Gottlieb

The FDA, since the appointment of Scott Gottlieb as commissioner, has made strong noises about tackling the opioid crisis and …

News
artificial-intelligence-2228610_960_720

Data-driven insights: Keeping pace with the technological boom

June 8, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, data, technology

If you want to understand the importance of data, look at Google and Facebook – neither company is out of …

Feature
vaccine

Calls strengthen for HPV vaccine for boys

June 8, 2017
Medical Communications, Research and Development HPV, HPV vaccine

The human papillomavirus (HPV) vaccine began to be implemented in the UK in 2008. It started by immunising girls between …

News
brain-770044_960_720

Blood biomarker found to track development of Huntington’s disease

June 8, 2017
Research and Development UCL, huntington's disease

Huntington’s disease (HD) is a rare and incurable hereditary condition of the central nervous system. The condition can cause involuntary …

News

AbbVie posts promising data on RA drug

June 8, 2017
Research and Development AbbVie, JAK inhibitor

AbbVie posted results on upadacitinib, the latest drug in its pipeline for rheumatoid arthritis (RA) and the results have given …

News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026